Whether the presence of sGRP78+CXCR4+ leukemic cells could lead to an increased risk of relapse, which is presumed to occur in patients with myeloid leukemia that express high levels of GRP78 transcripts7, 39 should be further evaluated. The gene discussed is HSPA5; the disease is myeloid leukemia.